J&J publish series of Aurora A/VEGFR-1 inhibitors

J&J have published a series of Aurora A/VEGFR-2 inhibitors

AstraZeneca publish series of CSF-1R inhibitors for the treatment of cancer

AstraZeneca have published a series of pyridyl and thiazolyl bisamide CSF-1R inhibitors for the treatment of cancer

Amgen publish series of Indazole KDR/VEGFR-2 Inhibitors

Amgen have published a series of Indazole KDR/VEGFR-2 Inhibitors

Incyte report on INCB18424 and INCB28050 progress

In 2nd quarter results Incyte have provided an update on JAK2 inhibitors INC18424 and INCB28050

ARIAD commence Phase II trial of oral deforolimus in breast cancer

ARIAD have announced the initiation of a Phase II clinical trial of mTOR inhibitor Deforolimus in Patients with Metastatic, HER2-Positive Breast Cancer

Novartis publish series of CDC7 inhibitors

Novartis have published a series of 4-(1H-Indazol-5-yl)-6-phenylpyrimidin-2(1H)-one analogs as potent CDC7 inhibitors